Tokyo, April 23 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061350) titled 'Effects of Using Home-Use Facial Devices on Skin Condition and Body Contour' on April 23.

Study Type: Interventional

Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Open -but assessor(s) are blinded Control - No treatment

Primary Sponsor: Institute - Japan Clinical Trial Association

Condition: Condition - Healthy adult Female Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - The Effects of Using Home-Use Beauty Devices on Skin Condition and Body Contours Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - Use the beauty device and a specific gel on one side of the face and body for 4 weeks (however, apply to the entire waist and hips). Interventions/Control_2 - Do not apply the test product to the other side of the face and body.

Eligibility: Age-lower limit - 35 years-old

Gender - Female Key inclusion criteria - Subjects who are aware of loss of facial firmness, dark spots, wrinkles, visible pores, or sagging of the body BMI of 20 or higher but less than 25.0 Subjects who can use the test device on one side of their face and body for just under 30 minutes every day during the trial period Subjects who can commit to not changing their lifestyle habits (diet, exercise, sleep, and skincare routines) Key exclusion criteria - Subjects with cosmetic allergies, atopic dermatitis, or skin prone to irritation Subjects who are sensitive to the tingling sensation characteristic of facial beauty devices Subjects with a history of inflammation, eczema, excessive dryness, or contact dermatitis at the treatment site Subjects who have undergone procedures such as laser treatment, thread lifts, Botox, hyaluronic acid injections, or liposuction at the treatment site within the past six months, or who plan to undergo such procedures during the trial period Subjects with metal implants (such as bolts or pacemakers) or those with severe metal allergies Pregnant or breastfeeding individuals Subjects currently undergoing hormone replacement therapy Subjects taking supplements or medications that may affect the efficacy of the test product Subjects with eyelash extensions or permanent makeup (such as eyeliner) around the eyes Subjects who have participated in a human clinical trial within the past month, or who plan to do so during the trial period Target Size - 12

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2026 Year 03 Month 25 Day Date of IRB - 2026 Year 03 Month 26 Day Anticipated trial start date - 2026 Year 04 Month 20 Day Last follow-up date - 2026 Year 05 Month 20 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070194

Disclaimer: Curated by HT Syndication.